The interaction among OSA, CPAP, and medications in patients with comorbid OSA and cardiovascular/cerebrovascular disease: a randomized controlled trial

The interaction among OSA, CPAP, and medications in patients with comorbid OSA and cardiovascular/cerebrovascular disease: a randomized controlled trial

Abstract Background Most patients with comorbid sleep apnea (OSA), cardiovascular (CV) disease, and/or cerebrovascular (CeV) disease simultaneously take medications. Whether OSA and continuous positive airway pressure (CPAP) interact with CV/CeV medications remains unknown. This study aimed to deter...

Full description

Bibliographic Details
Main Authors: Miaochan Lao, Yilu Cheng, Xinglin Gao, Qiong Ou
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Pulmonary Medicine
Subjects:
Obstructive sleep apnea
Cardiovascular disease
Cerebrovascular disease
Medication
Prognosis
Online Access:https://doi.org/10.1186/s12890-022-01879-2

Internet

https://doi.org/10.1186/s12890-022-01879-2

Similar Items